Carroll Financial Associates’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$36K Sell
292
-8
-3% -$981 ﹤0.01% 816
2021
Q3
$36K Buy
300
+16
+6% +$1.95K ﹤0.01% 833
2021
Q2
$31K Sell
284
-4
-1% -$421 ﹤0.01% 958
2021
Q1
$27K Hold
288
﹤0.01% 934
2020
Q4
$22K Sell
288
-4
-1% -$290 ﹤0.01% 897
2020
Q3
$18K Sell
292
-1,068
-79% -$69.5K ﹤0.01% 894
2020
Q2
$89K Buy
1,360
+1,068
+366% +$64K 0.01% 498
2020
Q1
$13K Sell
292
-4
-1% -$200 ﹤0.01% 882
2019
Q4
$16K Sell
296
-40
-12% -$2.1K ﹤0.01% 933
2019
Q3
$16K Hold
336
﹤0.01% 884
2019
Q2
$17K Buy
336
+36
+12% +$1.81K ﹤0.01% 875
2019
Q1
$14K Hold
300
﹤0.01% 855
2018
Q4
$10K Hold
300
﹤0.01% 862
2018
Q3
$15K Hold
300
﹤0.01% 796
2018
Q2
$11K Hold
300
﹤0.01% 839
2018
Q1
$11K Hold
300
﹤0.01% 817
2017
Q4
$9K Hold
300
﹤0.01% 862
2017
Q3
$9K Sell
300
-800
-73% -$23.7K ﹤0.01% 846
2017
Q2
$32K Sell
1,100
-40
-4% -$1.09K ﹤0.01% 582
2017
Q1
$28K Hold
1,140
﹤0.01% 593
2016
Q4
$29K Hold
1,140
﹤0.01% 565
2016
Q3
$31K Hold
1,140
﹤0.01% 558
2016
Q2
$32K Hold
1,140
0.01% 523
2016
Q1
$26K Buy
1,140
+800
+235% +$17.6K ﹤0.01% 555
2015
Q4
$7K Hold
340
﹤0.01% 814
2015
Q3
$8K Buy
340
+36
+12% +$903 ﹤0.01% 765
2015
Q2
$7K Buy
+304
New +$7.59K ﹤0.01% 794

Other funds holding TECH

Carroll Financial Associates's TECH Position: Q4 2021 in Review

Carroll Financial Associates reduced its Bio-Techne (TECH) stake by 2.7% in Q4 2021, selling an estimated $981 and leaving 292 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Carroll Financial Associates first reported a position in TECH in Q2 2015 and has held it in 27 quarters since. The position peaked at $89K in Q2 2020. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

  • Carroll Financial Associates held 292 shares of Bio-Techne worth $36K as of Q4 2021.
  • Carroll Financial Associates sold 8 Bio-Techne shares in Q4 2021, an estimated $981.
  • Bio-Techne made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #816 holding.
  • Carroll Financial Associates first reported a position in Bio-Techne in Q2 2015 and has held it in 27 quarters since.
  • Carroll Financial Associates's Bio-Techne position peaked at $89K in Q2 2020.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.